http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201000771-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-16
filingDate 2007-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201000771-A1
titleOfInvention TETRACYCLIC DIPIRANOCUMARINE CONNECTIONS WITH ACTIVITY AGAINST HIV AND MYCOBACTERIUM TUBERCULOSIS
abstract The present invention relates to tetracycline dipiranocoumarin compounds of the general formula (I), wherein the substituents are as defined herein. These compounds exhibit dual biological activity against infection of the human immunodeficiency virus type 1 (HIV-1) and against Mycobacterium tuberculosis (TB) infection.
priorityDate 2007-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533562

Total number of triples: 25.